Skip to content

Using Tablets for Upper Extremity Rehabilitation Post Acquired Brain Injury

Using Tablets for Upper Extremity Rehabilitation Post Acquired Brain Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02136433
Acronym
TBL
Enrollment
40
Registered
2014-05-13
Start date
2014-02-28
Completion date
Unknown
Last updated
2014-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injury, Stroke

Keywords

Hand, Rehabilitation, Stroke, Brain-injury, Tablet

Brief summary

The purpose of the study is to test the effectiveness of training using novel tablet applications for hand function, compared to traditional hand exercises. In addition, we aim to examine brain plasticity following treatment with the new tablet applications. We hypothesize that training with a tablet would prove to be more effective than traditional exercises. We expect to observe neuroplastic changes in the brain in patients who practiced finger movements using the tablet.

Interventions

DEVICETablet - self exercise
OTHERGRASP self exercise

Sponsors

Tel-Aviv Sourasky Medical Center
CollaboratorOTHER_GOV
Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* At least one week post Brain injury or stroke * Partial ability to open and close their hand (fingers) * Full function of the hands prior to the injury or event * Intact or Corrected vision * Cognitively intact or mild impairment

Exclusion criteria

* Other neurological conditions besides the brain injury or stroke * Orthopedic conditions of the upper extremity

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in score of the Nine Hole Peg TestAn average of one week before intervention and one week after interventionTo assess dexterity of the affected hand. This test is a assesses dexterity and the time to remove and return nine pegs is measured. The Nine Hole Peg Test is a reliable, valid and responsive measure in clients with stroke

Secondary

MeasureTime frameDescription
Grip and pinch strengthAn average of one week before intervention and one week after interventionAssessed by the Jamar dynamometer. This is a valid and reliable way to assess grip and pinch strength of individuals recovering from stroke.
Visual Analogue ScaleAn average of one week before intervention and one week after interventionQuantifies the perceived level of pain intensity on a scale of 0-10 cm.
The System Usability ScaleAn average of one week after interventionThis questionnaire includes 10 items which provide a global view of subjective assessment of a system's usability.
The Fugl-Meyer Motor AssessmentAn average of one week before intervention and one week after interventionTo quantify the level of the motor impairment. The participants are required to perform different movements. Each movement is rated 0 (inability to perform) to 2 (full movement). The total score ranges from 0 (no active movements) to 60 points (full movements).
Self - report complianceAn average of one week after interventionMean self-training time per day.
Satisfaction QuestionnaireAn average of one week after interventionDeveloped for the study and will query how much the subjects were satisfied with the self-training intervention they experienced and to what extent they think it can help them to improve their upper extremity function. Responses will be rated on a scale of 1-5.
Change from baseline in score of the Action Research Arm TestAn average of one week before intervention and one week after interventionAssesses the functional ability of the upper extremity by grasping and moving objects of different size and weight. It has four subtests; grasp, grip, pinch and gross movement. The total score is out of 57 points.

Countries

Israel

Contacts

Primary ContactGabi Zeilig, MD
gabi.zeilig@sheba.health.gov.il+972-3-5303725

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026